Magna-Lab's intravascular MRI (magnetic resonance imaging) coil shows promise
This article was originally published in Clinica
Executive Summary
Magna-Lab has reported that an animal study to assess its intra-vascular MRI catheter coil as a means of diagnosing coronary artery disease has produce positive results. The resolutions of images obtained with the intra-vascular coil "far surpass the resolution possible with optimised surface coils, which is the best technology used today", said Dr Motoya Hayase, of the Massachusetts General Hospital (MGH) - where the trial was conducted. The device, which is used with MRI technology, consists of an intra-vascular MRI coil that is threaded through a catheter and guide-wire to the site of the atherosclerotic blockage.
You may also be interested in...
BioCryst’s Oral Option To Take On Injectables In HAE Prophylaxis Market
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
STRENGTH Results May Weaken Chances For Omega-3 Fatty Acid Heart Health Claims
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.
FDA To Combo Product Sponsors: Consider Traditional Pathways Before Asking For Meeting
In a final guidance from the US agency, regulators say most combination product questions are best resolved through traditional pathways and noted that initiating a so-called combination product agreement meeting may be unproductive.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: